Population (July 2006 estimate)
25.7m
GDP (2005 - PPP basis)
$164.1bn
Health expenditure (2004)
Health expenditure as proportion of GDP (2004)
Size of pharmaceutical market (2004 estimate)
Percentage of GDP spent on pharmaceuticals (2004)
Percentage of health expenditure spent on medicines (2004)
Pharmaceutical market growth rate
Local currency
Venezuelan Bolivar (VEB)
Summary: Venezuela
Political unrest and opposition to the government has led to a series of economic crises. In the healthcare sector, this has led to a shortage of medical supplies. In order to reduce healthcare costs, the government has moved towards directly intervening in pricing. Manufacturers have opposed these measures.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
There are no news items for this country.
View all articles for Latin America »
Related Items